Tariff on imported products for drugs would be hard for US pharma to swallow
Looming tariffs on imported pharmaceuticals could push up the cost of US drugs by $51bn ...
© Piotr Trojanowski
CH Robinson experienced a near 40% surge in ebit over the three months to April, reaching $177m, despite seeing revenues fall more than 8% year on year.
Group revenue for the first quarter hit $4bn, 8.3% less than in the same period last year, as its global forwarding unit posted a 9.8% dip, to $775m, and its far larger North American surface transportation (NAST) operations recorded a 4.4% revenue decline, to $2.8bn.
Even so, Q1 divisional ...
Comment on this article